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Case Presentation
A 51-year-old woman underwent implantation of a dual
chamber pacemaker 10 years ago, for symptomatic intermit-
tent second-degree type II AV block. She remained free of
symptoms during follow-up. Recently, she underwent pace-
maker replacement because of battery depletion (Adapta
ADDR01, Medtronic Inc., Minneapolis, MN, USA). Given
intact AV conduction at the time of intervention, the Managed
Ventricular Pacing mode algorithm (MVPTM, Medtronic),
which provides AAI(R) pacing with ventricular monitor-
ing and backup DDD/R pacing as needed, was programmed
with a lower rate limit of 60 ppm and an upper rate limit of
130 ppm.
Ten days after the procedure, the patient complained of
asthenia, dyspnea, and presyncope. ECG at pacemaker inter-
rogation revealed sinus tachycardia with second-degree type
II AV block (Fig. 1). Atrial pacing artifacts with atrial capture
are seen dissociated from the native QRS complexes. Pace-
maker interrogation revealed pacing and sensing thresholds
as well as impedances within normal range. In our patient,
the repetitive atrial pacing during ventricular systole led to
pacemaker syndrome and symptoms resolved by reprogram-
ming the device to AV sequential pacing without MVP. What
is the mechanism of atrial stimulation dissociated from the
native QRS complexes?
Discussion
Pacemaker ECG with marker annotation (Fig. 2A) showed
that dissociated atrial pacing stimuli were related to func-
tional undersensing, with atrial native beats falling within
the refractory period after sensed or paced atrial beats, pre-
venting the resetting of the atrial timer as the pacemaker
operated in AAI mode. At the end of the atrial lower rate
interval, atrial stimulation is delivered dissociated from the
native QRS complexes. This case illustrates a particular cause
of pacemaker syndrome resulting from two related mecha-
nisms: (1) functional undersensing of sinus beat related to the
atrial refractory period operated by the device during MVP
mode and (2) failure of the unit to switch from AAI (R) to
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DDD (R) pacing mode despite a second-degree type II AV
block. During MVP, the AAI(R) mode operates with a dy-
namic atrial refractory period (ARP) set either to 75% of the
R–R cycle length if heart rate is 75 bpm or faster, or to 600 ms
if heart rate is slower than 75 bpm. The purpose of dynamic
ARP is to avoid inappropriate switches to DDD(R) mode in
the presence of (nonconducted) premature atrial contractions
and to ensure that the atrial escape interval is only reset after
true P waves. When the device is operating in MVP mode,
ventricular pacing may be delivered in case of intermittent
or transient loss of AV conduction. This backup ventricular
pacing is scheduled to occur after any A–A interval in which
there is no ventricular sensed event, and occurs 80 ms after
the scheduled atrial pace (i.e., 80 ms after the escape A–A
interval). MVP switches the device from AAI(R) to DDD(R)
when there is evidence of persistent loss of AV conduction
defined as the absence of ventricular sensed event for 2 out of
the last 4 pacing cycles (the four most recent A–A intervals).
This aims to prevent inappropriate switches following single
nonconducted atrial events.
As illustrated on the ECG (Fig. 2B), native sinus beats
repetitively fall in the ARP since the device operates a re-
fractory period based on the R–R cycle length rather than on
the A–A interval, which is half shorter. Two consequences
derive from this condition: first, refractory sinus beats do not
reset the timer of atrial escape interval (1000 ms) and, as a
consequence, pacing stimuli are delivered dissociated from
the QRS complexes. Second, repetitive sinus beats falling
in the ARP provide the condition for failure to switch to
DDD(R) mode since ventricular sensed events persistently
occur during each pacemaker A–A interval (the atrial escape
interval instead of the sinus beat interval) despite second-
degree type II AV block. A similar inappropriate mode of
operation is shown in another patient with sinus tachycardia
and second-degree type I 4:3 AV block (Fig. 3).
Conclusion
With an increased understanding of the potential detri-
mental effects of right ventricular pacing,1-4 new pacing al-
gorithms such as the MVP mode have been developed to
minimize ventricular pacing. This case illustrates that MVP
feature may potentially lead to pacemaker syndrome in pa-
tients with second-degree AV block. The randomized studies
of MVP to date have been mainly restricted to patients with
intact AV conduction with only about 6% of the enrolled
patients with previously documented AV block.3,5,6 There-
fore, we have little knowledge of the actual clinical impact
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Figure 1. ECG 10 days after pacemaker replacement. Note the atrial pacing artifacts (arrows) dissociated from the native QRS complexes.
Figure 2. A: Pacemaker ECG with marker annotation during MVP operation. Note the atrial pacing stimulus (AP) following functional undersensing of
atrial sinus beats falling within the refractory period (AR∗) triggered by sensed atrial beats (AS), preventing the resetting of the atrial timer as the pacemaker
operates in AAI mode. B: ECG with marker annotation and timing of the atrial refractory period (ARP) and lower rate interval (LRI) operated by the device
illustrating the aforementioned observations. Note that the functionally undersensed sinus beats (AR) falling in the ARP provide the condition for failure to
switch to DDD(R) mode, since ventricular sensed events (VS) persistently occur between two consecutive atrial sensed or paced events.
Figure 3. ECG and stored electrogram with marker annotation in a patient with sinus tachycardia and second-degree type I 4:3 AV block. A similar
inappropriate mode of operation is illustrated with sinus beats falling within the atrial refractory period (AR) with atrial pacing artifacts (AP) dissociated
from the native QRS (VS). The pacemaker does not switch to DDD(R) mode since, except on two separate occasions (∗∗), ventricular sensed events always
occur between two consecutive atrial sensed or paced events.
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of this inappropriate mode of operation, and careful consid-
eration should be given to this potential drawback in patients
with intermittent second-degree AV block or who develop
symptoms suggestive of pacemaker syndrome during MVP
mode.
Since the atrial refractoy period operated by the device
during MVP mode is a nonprogrammable feature, the only
programming option is to inactivate the MVP mode and, if
desired, to program the Search AV + feature to promote
intrinsic ventricular activation in the event of restored AV
conduction and to prevent inappropriate long AV delay if AV
block persists.
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